Biotech Startups
9,990 companies tagged Biotech, with their investors and founders.
0 investors
BrainXell is a company focused on advancing research and improving patient outcomes through scientific work and services. Its stated mission centers on neuroscience-related research, associated with Dr. Su-Chun Zhang.
0 investors
Branch Therapeutics develops first-in-class, orally available dual-kinase inhibitors designed to modulate WNT/Ξ²-catenin and PI3KΞ± signaling to target cancer stem cells and treatment resistance in solid tumors. The company pairs its therapies with a precision biomarker strategy aimed at safer, longer-lasting responses to cancer treatment.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
BrickBio develops protein and antibody-drug conjugate (ADC) therapeutics using its Evolved tRNA Localization (ETRNAL) platform, which incorporates synthetic amino acid conjugation handles at specific sites in a protein backbone via mammalian expression systems. The company targets pharmaceutical and biotech applications, aiming to produce more stable and efficacious conjugated biologics, including multi-payload conjugates.
0 investors
0 investors
Bridge Therapeutics is a development-stage pharmaceutical company developing BT-219 (Bunalz), a buprenorphine/naloxone orally disintegrating tablet for Opioid Use Disorder, and BT-205, a buprenorphine/meloxicam sublingual combination for chronic pain in opioid-experienced patients. Both drug candidates are being pursued through the FDA 505(B)(2) approval pathway.
0 investors
0 investors
0 investors
0 investors
0 investors
Bruker provides preclinical imaging solutions for research across oncology, neurology, cardiology, and other disease areas, serving academic institutions and pharmaceutical researchers.
0 investors
0 investors
Bullseye Biodevices develops a multimodal biosensing platform that combines mechanical, electrical, and optical sensing to assess tissue and organ condition in real time. The technology targets medical applications including tumor localization and surgical margin assessment, skin health monitoring, and organ evaluation during surgery, preservation, and transplantation.
0 investors
Burke Therapeutics is a pharmaceutical company that markets prescription products to physicians and pharmacies across the United States and develops early-stage drug candidates for dermatological conditions with limited treatment options.
0 investors
0 investors
0 investors
0 investors
C2N Diagnostics develops and commercializes blood-based diagnostic tests for Alzheimer's disease and other neurodegenerative conditions, using proprietary LC-MS/MS mass spectrometry to detect brain amyloid pathology. Its PrecivityAD, PrecivityAD2, and Precivity-ApoE tests serve health care professionals evaluating patients with cognitive impairment, available across all 50 US states and the District of Columbia.
0 investors